Cargando…
Update and new approaches in the treatment of Castleman disease
First described 60 years ago, Castleman disease comprises a rare and heterogeneous cluster of disorders, characterized by lymphadenopathy with unique histological features and associated with cytokine-driven constitutional symptoms and biochemical disturbances. Although unicentric Castleman disease...
Autores principales: | Chan, Kah-Lok, Lade, Stephen, Prince, H Miles, Harrison, Simon J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976903/ https://www.ncbi.nlm.nih.gov/pubmed/27536166 http://dx.doi.org/10.2147/JBM.S60514 |
Ejemplares similares
-
Updates on the diagnosis and management of multicentric Castleman disease
por: Wu, Ya-Ju, et al.
Publicado: (2020) -
Castleman disease
por: Saeed-Abdul-Rahman, Ibrahiem, et al.
Publicado: (2012) -
A Case of Retroperitoneal Castleman's Disease and an Update on the Latest Evidence
por: Spartalis, Eleftherios, et al.
Publicado: (2014) -
Castleman disease and TAFRO syndrome
por: Masaki, Yasufumi, et al.
Publicado: (2022) -
Castleman's disease
por: Srivastava, Himanshu, et al.
Publicado: (2020)